• Continued growth of Indonesian seaweed trading platform with ~A$2.57 million in aggregate gross sales
• Successful $1.0 million strategic placement to strengthen working capital and enable scaling of trading operations
• Expanded R&D pipeline across multiple verticals including precious metals recovery, biofuel production, and animal feed applications

During the March 2026 quarter, BPH Global continued to execute its dual-track strategy of scaling its revenue-generating Indonesian seaweed trading operations while advancing a diversified portfolio of higher-value research and development initiatives. The company's Indonesian platform delivered ongoing revenue growth, with gross sales of approximately A$205,933 for Month 9 and A$213,174 for Month 10, bringing total cumulative sales to approximately A$2.57 million across the first ten months of trading operations. While trading activity was influenced by seasonal factors, the company observed no deterioration in underlying demand, with continued engagement across domestic and export channels and stable customer relationships. BPH also completed a $1.0 million strategic placement at market price, strengthening its balance sheet and enabling increased deployment of capital toward expanding procurement volumes, export activity, and independent trading operations. In parallel, the company significantly expanded its R&D pipeline, progressing multiple initiatives across nutraceuticals, agriculture, energy and mineral recovery. Key developments included the completion of formulation for Project Giddy-Up, the execution of a binding MoU with Indonesia's National Research and Innovation Agency, and the advancement of programs focused on precious metals recovery, biofuel production, animal feed applications, and bio-stimulant/bio-fertiliser development.

BPH Global enters the next quarter with a strengthened commercial and strategic position, underpinned by a growing revenue base and an expanding R&D pipeline. As seasonal conditions improve, the company expects increased trading volumes supported by established demand and enhanced working capital. In parallel, its R&D initiatives continue to progress toward potential commercial pathways across multiple sectors.